Calidi Biotherapeutics, Inc.

CLDI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Aug 19, 2026 4
4 Aug 19, 2026 4
4 Aug 19, 2026 4
4 Aug 19, 2026 4
4 Aug 19, 2026 4
4 Aug 19, 2026 4
4 Aug 19, 2026 4
4 Aug 19, 2026 4
SCHEDULE 13G/A Aug 14, 2026
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
8-K Jul 31, 2026 8-K
8-K Jul 16, 2026 8-K
3 Jun 29, 2026 3
8-K Jun 23, 2026 8-K
8-K Jun 18, 2026 8-K
DEFA14A Jun 5, 2026 DEFA14A
8-K May 29, 2026 8-K
SCHEDULE 13G May 15, 2026
10-Q May 14, 2026 10-Q
8-K May 14, 2026 8-K
8-K May 8, 2026 8-K
DEFA14A Apr 29, 2026 DEFA14A
DEF 14A Apr 29, 2026 DEF 14A
PRE 14A Apr 17, 2026 PRE 14A
← Newer Page 1 of 17 · 403 filings Older →